Major depressive disorder (Q34122147)

31 July 2017

1 reference

title

Major depressive disorder. (English)

1 reference

31 July 2017

2

Kendler KS

1 reference

31 July 2017

Fava M

1

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

31 July 2017

1 reference

31 July 2017

volume

28

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

335-341

1 reference

Addiction, dopamine, and the molecular mechanisms of memory

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2900112-4

7 January 2021

The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2900112-4

7 January 2021

Hippocampal volume reduction in major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2900112-4

7 January 2021

Effect of sertraline on regional metabolic rate in patients with affective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2900112-4

7 January 2021

Prefrontal cortical-amygdalar metabolism in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2900112-4

7 January 2021

A Molecular and Cellular Theory of Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2900112-4

7 January 2021

The responsiveness of the Hamilton Depression Rating Scale

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2900112-4

7 January 2021

Definition and epidemiology of treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2900112-4

7 January 2021

The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2900112-4

7 January 2021

Initiation and adaptation: a paradigm for understanding psychotropic drug action

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2900112-4

7 January 2021

Short-Term Psychotherapy of Depressive Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2900112-4

7 January 2021

Stressful life events, genetic liability, and onset of an episode of major depression in women

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2900112-4

7 January 2021

Clinical characteristics of major depression that predict risk of depression in relatives

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2900112-4

7 January 2021

THE EFFECTS OF STRESSFUL LIFE EVENTS ON DEPRESSION

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2900112-4

7 January 2021

Reduced Levels of Norepinephrine Transporters in the Locus Coeruleus in Major Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2900112-4

7 January 2021

Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2900112-4

7 January 2021

Limbic-cortical dysregulation: a proposed model of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2900112-4

7 January 2021

Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2900112-4

7 January 2021

Recovery, chronicity, and levels of psychopathology in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2900112-4

7 January 2021

Evidence-Based Health Policy---Lessons from the Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2900112-4

7 January 2021

Study duration in antidepressant research: advantages of a 12-week trial

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2900112-4

7 January 2021

Hippocampal damage associated with prolonged glucocorticoid exposure in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2900112-4

7 January 2021

Brain Serotonin1A Receptor Binding Measured by Positron Emission Tomography With [11C]WAY-100635

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2900112-4

7 January 2021

d,l-fenfluramine response in impulsive personality disorder assessed with [18F]fluorodeoxyglucose positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2900112-4

7 January 2021

The anatomy of mood disorders--review of structural neuroimaging studies

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2900112-4

7 January 2021

Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2900112-4

7 January 2021

Genetic epidemiology of major depression: review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2900112-4

7 January 2021

Depressive characteristics of FSL rats: involvement of central nicotinic receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2900112-4

7 January 2021

Control of alternative splicing of potassium channels by stress hormones.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2900112-4

7 January 2021

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2900112-4

7 January 2021

10.1016/S0896-6273(00)00112-4

Identifiers

DOI

1 reference

31 July 2017

1 reference